The goal of this project is to apply methods for high throughput structure determination to target proteins from NIAID Category A-C priority organisms. The selected target proteins are be involved in pathogenesis, essential to the pathogen’s life cycle, involved in drug resistance, or potential candidates for drug or vaccine development.
|Effective start/end date||9/1/17 → 8/31/22|
- National Institute of Allergy and Infectious Diseases (HHSN272201700060C)
National Institute of Allergy and Infectious Diseases (U.S.)
Life Cycle Stages